November 23, 2016 - By Michael Collier
Stryker Corp director and an insider Ronda Stryker lately sold 12,000 company shares with a total value of $1,318,730 at an average cost of $109.9. Ronda is trying to quietly decrease her company’s share, same as she did in the last 30 days. She unloaded another 132,000 shares worth $14,968,409 USD. Currently, Mr. Ronda, holds 24.00 million shares, which accounts for 6.36% of the Company’s market cap. The insider’s activity definitely generated quite an interest in the stock community.
Out of 19 analysts covering Stryker Corporation (NYSE:SYK), 11 rate it a “Buy”, 2 “Sell”, while 6 “Hold”. This means 58% are positive. $130 is the highest target while $88 is the lowest. The $109.83 average target is -1.59% below today’s ($111.6) stock price. Stryker Corporation has been the topic of 25 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, August 12. On Wednesday, April 13 the stock rating was downgraded by Robert W. Baird to “Neutral”. The rating was downgraded by BMO Capital Markets to “Underperform” on Monday, December 14. As per Monday, August 10, the company rating was reinitiated by Credit Suisse. The firm has “Buy” rating given on Wednesday, August 5 by Argus Research. The firm has “Hold” rating given on Monday, September 28 by Needham. On Friday, October 14 the stock rating was initiated by Suntrust Robinson with “Buy”. The firm has “Buy” rating given on Friday, October 14 by SunTrust. On Wednesday, April 27 the stock rating was maintained by Argus Research with “Buy”. The rating was initiated by Sterne Agee CRT with “Neutral” on Wednesday, November 4.
Insitutional Activity: The institutional sentiment decreased to 0.79 in 2016 Q2. Its down 0.14, from 0.93 in 2016Q1. The ratio dived, as 41 funds sold all Stryker Corporation shares owned while 325 reduced positions. 61 funds bought stakes while 280 increased positions. They now own 279.01 million shares or 2.26% less from 285.46 million shares in 2016Q1.
Old Second Commercial Bank Of Aurora accumulated 0.01% or 100 shares. The Illinois-based Private Bancorporation Com has invested 0.08% in Stryker Corporation (NYSE:SYK). Zebra Capital Limited Company reported 11,993 shares or 0.5% of all its holdings. Department Mb Natl Bank N A last reported 1,015 shares in the company. Carnegie Capital Asset Management Limited Liability Com, a Ohio-based fund reported 30,997 shares. The Ohio-based Eubel Brady Suttman Asset Mngmt has invested 4.03% in Stryker Corporation (NYSE:SYK). Public Employees Retirement Association Of Colorado holds 70,624 shares or 0.07% of its portfolio. Eastern Bank & Trust, a Massachusetts-based fund reported 98,447 shares. Moreover, Connors Investor Services has 1.68% invested in Stryker Corporation (NYSE:SYK) for 72,131 shares. Caz Limited Partnership holds 1.85% of its portfolio in Stryker Corporation (NYSE:SYK) for 14,530 shares. Moreover, Sii Invests Wi has 0.03% invested in Stryker Corporation (NYSE:SYK) for 3,011 shares. Stewart And Patten owns 117,797 shares or 2.77% of their US portfolio. Mitsubishi Ufj Tru Banking Corporation has 714,112 shares for 0.19% of their US portfolio. Waldron Limited Partnership owns 92,000 shares or 3.74% of their US portfolio. Putnam Lc holds 6,601 shares or 0% of its portfolio.
Insider Transactions: Since May 25, 2016, the stock had 2 buys, and 63 insider sales for $84.93 million net activity. STRYKER RONDA E also sold $1.39 million worth of Stryker Corporation (NYSE:SYK) on Friday, September 2. COX HOWARD E JR sold $1.11M worth of stock or 9,448 shares. Doliveux Roch bought 46 shares worth $5,308. The insider Owen Katherine Ann sold 10,686 shares worth $1.28 million. $129,987 worth of Stryker Corporation (NYSE:SYK) was sold by Becker Yin C. 9,945 shares with value of $1.10 million were sold by Scannell Timothy J on Tuesday, May 31. 6,565 shares were sold by Datar Srikant, worth $747,754 on Monday, June 6.
About 867,112 shares traded hands. Stryker Corporation (NYSE:SYK) has risen 1.27% since April 21, 2016 and is uptrending. It has underperformed by 4.06% the S&P500.
Stryker Corporation is a medical technology company. The company has a market cap of $41.50 billion. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. It has a 25.44 P/E ratio. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries.
According to Zacks Investment Research, “Stryker Corporation develops, manufactures, and markets specialty surgical and medical products, including orthopaedic implants, bone cement, trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services.”
Analysts await Stryker Corporation (NYSE:SYK) to report earnings on January, 24. They expect $1.76 earnings per share, up 12.82% or $0.20 from last year’s $1.56 per share. SYK’s profit will be $654.48 million for 15.85 P/E if the $1.76 EPS becomes a reality. After $1.39 actual earnings per share reported by Stryker Corporation for the previous quarter, Wall Street now forecasts 26.62% EPS growth.
Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Firm offers its products to doctors, hospitals and other healthcare facilities. The Company’s products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, and neurosurgical, neurovascular and spinal devices, as well as other medical device products used in a range of medical specialties. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. The Firm offers a 1588 advanced imaging modalities (AIM) platform, which is designed for optimum visualization across surgical specialties.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.